facebook
twitter
search
search

Congress questions 1-800-GET-THIN ads

Jan. 21, 2012 at 3:23 PM

LOS ANGELES, Jan. 21 (UPI) -- U.S. lawmakers are calling for an investigation into ad campaigns that promote weight-loss surgery.

Rep. Henry A. Waxman, D-Beverly Hills, and two other House members called for the congressional hearings to examine whether 1-800-GET-THIN ads properly disclose the dangers of the surgical procedure, the Los Angeles Times reported Friday.

The representatives also questioned the safety and long-term effectiveness of the Lap-Band, the device used in the surgery.

In a letter to chairman of the House Energy and Commerce Committee, Waxman said Congress should subpoena documents from 1-800-GET-THIN and Lap-Band manufacturer Allergan Inc.

"We believe the Committee should hold hearings to examine whether [Food and Drug Administration] device regulation has been ineffective in protecting the public from dangerous medical devices like the Lap-Band," Waxman and Reps. Diana DeGette, D-Colo. and John Dingell, D-Mich., said in the letter.

Since 2009, five patients have died after getting Lap-Band surgeries at 1-800-GET-THIN affiliated facilities, the newspaper said.

A spokeswoman for Allergan, of Irvine, Calif., said the device, a ring that is surgically implanted around the stomach to discourage overeating, is safe and effective, if "inserted by an experienced and qualified bariatric surgeon who offers the patient appropriate follow-up care."

In December, the FDA sent warning letters to 1-800-GET-THIN and some of its affiliated surgery centers, saying the ads were misleading and did not properly disclose the dangers of Lap-Band surgery.

Robert Silverman, president of 1-800-GET-THIN, said they responded to FDA concerns by adding a disclosure on its Web site that said Lap-Band procedures can result in death.

Like Us on Facebook for more stories from UPI.com  
Latest Headlines
Top Stories
Elastic gel stops bleeding, helps wounds heal
FDA to look at risks of treating children with codeine
Device helps doctors personalize chemotherapy for patients